Vimarsana
Biggest News Aggregation in the World

Page 2 - Dana Walker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dana Walker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dana Walker Today - Breaking & Trending Today

Former Mississippi school financial secretary pleads guilty to embezzlement - Vimarsana News

Former Mississippi school financial secretary pleads guilty to embezzlement

JACKSON, Miss. (WJTV) - The former financial secretary for H.W. Byers High School pled guilty to embezzlement. State Auditor Shad White said Dana Walker was initially arrested in February 2022 by Marshall County School District Police. The case was then turned over to the Office of the State Auditor for further investigation. According to White, Walker [...]

European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite... - Vimarsana News

European Medicines Agency Validates Bristol Myers Squibb's Application for Opdivo (nivolumab) Plus Yervoy (ipilimumab) for the First-Line Treatment of Adult Patients with Microsatellite...

Application based on results from the CheckMate -8HW study, in which Opdivo plus Yervoy demonstrated statistically significant and clinically meaningful improvement in progression-free survival...

Bristol Myers: EMA submission for colorectal cancer - Vimarsana News

Bristol Myers: EMA submission for colorectal cancer

Bristol Myers Squibb announces that the European Medicines Agency has validated its application for Opdivo + Yervoy as first-line treatment for adult patients with metastatic colorectal cancer with...

EMA Validates Frontline Nivolumab Plus Ipilimumab for MSI-H/dMMR mCRC - Vimarsana News

EMA Validates Frontline Nivolumab Plus Ipilimumab for MSI-H/dMMR mCRC

The European Medicines Agency has validated an application for nivolumab plus ipilimumab for frontline MSI-H/dMMR metastatic colorectal cancer.

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma - Vimarsana News

CHMP Adopts Positive Opinion Recommending Approval of Bristol Myers Squibb's Opdivo® (nivolumab) in Combination with Cisplatin and Gemcitabine for the First-Line Treatment of Adult Patients with Unresectable or Metastatic Urothelial Carcinoma

Recommendation based on results from CheckMate -901, the first Phase 3 trial with an immunotherapy-chemotherapy combination to demonstrate a survival benefit versus standard-of-care chemotherapy...